Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2Ryuta Uraki, Aaron Rico, Maki Kiso et al.|Nature|2022Cited by 292
Inhaled Granulocyte/Macrophage–Colony Stimulating Factor as Therapy for Pulmonary Alveolar ProteinosisRyushi Tazawa, Koh Nakata, Nobuyuki Hizawa et al.|American Journal of Respiratory and Critical Care Medicine|2010Cited by 228
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2Yoshihiro Kawaoka, Tadaki Suzuki, Ryuta Uraki et al.|Research Square|2022Cited by 41